breast cancer mortality
Estrogen-blocking medications lower breast cancer mortality rates in high-risk women In a recent study, scientists used a computer model to reevaluate the long-term advantages and potential risks of estrogen-blocking medications for the prevention of breast cancer in women at high risk. Annual screening and estrogen-blocking drugs reduce the incidence of invasive breast cancer and breast cancer-related death by 40% and 57%, respectively, but they can potentially have a variety of mild to major adverse effects. Depending on risk variables such age, previous biopsy, and family history of breast cancer, the advantages and disadvantages of estrogen-blocking therapy differ from person to person. The study's findings, according to the researchers, should make choosing estrogen-blocking medications in clinical practise easier. 2021 research According to Trusted Source, women with oestrogen receptor-positive (ER-positive) breast cancer have a high probability of developing the disease aga